Company intelligence / Profile preview

Cyberonics

Houston, Texas, USA

Ownership: Private
Employees: ~650
Development stage: Other

Overview

Cyberonics was a medical technology company that pioneered the design, development, and commercialization of implantable medical devices for the treatment of epilepsy and other chronic neurological disorders. The company's core technology, Vagus Nerve Stimulation (VNS) Therapy, uses an implanted pulse generator and lead to deliver electrical signals to the vagus nerve. In 2015, Cyberonics merged with Sorin Group to form LivaNova, a global medical technology leader. The VNS Therapy system remains a standard of care for drug-resistant epilepsy and treatment-resistant depression.

Therapeutic areas: PsychiatryCardiovascularNeurology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Cyberonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyberonics.

Explore the full profile